Plasma Level Testing

Home/Tag: Plasma Level Testing

Importance of Therapeutic Drug Monitoring for Targeted Therapies

As personalized medicine has become an accepted paradigm, it may be time for oncologists to examine personalized dose levels.In a recent article from Cancer World, the author explores the value of therapeutic drug monitoring for [...]

By |2019-04-08T10:18:30-04:00May 1st, 2015|Drug Treatment, News|

Plasma Level Testing for Imatinib Now Available

Saladax Biomedical, a CLIA certified laboratory based in Bethlehem, Pennsylvania, is now providing plasma level testing for imatinib.(Gleevec). Testing is currently free of charge through January 31, 2015, as it is not covered by [...]

By |2019-04-08T08:46:39-04:00December 15th, 2014|Drug Treatment, Gleevec, News, Patient Support, Plasma Level Testing|

LRG & colleagues make their mark on 17th annual CTOS meeting in Prague

Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.

By |2019-09-20T13:18:16-04:00February 1st, 2013|Events, News|

Breaking News Update: TDM renews plasma testing

On April 21, 2010, the U.S. Food and Drug Administration (FDA) issued a warning letter to Novartis criticizing its promotion of blood level testing on its CML and GIST Alliance websites. As of September 30, 2010, Novartis terminated the CML and GIST Alliance programs which it had contracted with TDM Pharmaceutical Research, LLC. Since then, the Life Raft Group has been working tirelessly behind the scenes to try and resume this critical testing procedure as it has important potential for managing GIST patient care.

By |2019-04-08T09:08:13-04:00April 1st, 2011|News|
Go to Top